Suppr超能文献

扁桃体中免疫球蛋白 A 肾病患者的基因表达谱分析。

Microarray analysis of tonsils in immunoglobulin A nephropathy patients.

机构信息

Department of Geriatric Medicine and Nephrology, Osaka University, Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.

出版信息

Biochem Biophys Res Commun. 2010 Mar 19;393(4):565-70. doi: 10.1016/j.bbrc.2010.01.120. Epub 2010 Feb 6.

Abstract

BACKGROUND

Recently, combination of tonsillectomy and steroid pulse therapy was reported to be effective as the treatment of the immunoglobulin A nephropathy (IgAN). However, the gene expression difference between the tonsils in patients with IgAN and those in control patients is not established.

METHODS

We performed tonsillectomy combined with steroid pulse as a treatment to IgAN, analyzed the gene expression in the tonsils (N=23) using microarray, compared with those with patients suffering from chronic tonsillitis (N=22). From some candidate genes related with IgAN, we confirmed the apolipoprotein B messenger RNA-editing enzyme catalytic polypeptides 2 (APOBEC2) gene expression in the tonsil and we also analyzed its expression levels and clinical features.

RESULTS

Up-regulated genes seem to be categorized into two groups. One group belongs to the muscle related genes which might be caused by structural differences. The other group includes the immune system-related genes, such as APOBEC2, CALB2, DUSP27, and CXCL11. APOBEC2 was positively stained in the epithelium and the peripheral region of the germinal center in both tonsils. APOBEC2 expression level was negatively related with serum igg level, but did not correlate with clinical course after tonsillectomy.

CONCLUSION

We confirmed gene expression differences related with immune system and muscle structure. The APOBEC2 was confirmed to be elevated in the tonsils with IgAN patients, and the gene expression level was negatively related with serum igg level in overall patients. These results might be helpful to reveal the mechanism of IgAN.

摘要

背景

最近,扁桃体切除术联合类固醇脉冲疗法被报道对 IgA 肾病(IgAN)的治疗有效。然而,IgAN 患者和对照组患者扁桃体的基因表达差异尚未确定。

方法

我们对 IgAN 患者进行扁桃体切除术联合类固醇脉冲治疗,使用微阵列分析扁桃体中的基因表达(N=23),并与慢性扁桃体炎患者(N=22)进行比较。从一些与 IgAN 相关的候选基因中,我们确认了载脂蛋白 B mRNA 编辑酶催化多肽 2(APOBEC2)基因在扁桃体中的表达,并分析了其表达水平和临床特征。

结果

上调的基因似乎分为两组。一组属于与肌肉相关的基因,可能是由于结构差异引起的。另一组包括与免疫系统相关的基因,如 APOBEC2、CALB2、DUSP27 和 CXCL11。APOBEC2 在扁桃体的上皮细胞和生发中心的外周区域呈阳性染色。APOBEC2 的表达水平与血清 IgG 水平呈负相关,但与扁桃体切除术后的临床病程无关。

结论

我们证实了与免疫系统和肌肉结构相关的基因表达差异。APOBEC2 在 IgAN 患者的扁桃体中被证实上调,在所有患者中,基因表达水平与血清 IgG 水平呈负相关。这些结果可能有助于揭示 IgAN 的发病机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验